Clinical Trials Directory

Trials / Unknown

UnknownNCT05595564

Influence of PBM on Anaerobic Capacity Under Normoxia and Hypoxia

Influence of Photobiomodulation on Anaerobic Capacity Under Normoxia and Hypoxia Conditions in Treadmill Runners

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
Male
Age
18 Years – 29 Years
Healthy volunteers
Accepted

Summary

The photobiomodulation (PBM) shows positive results in muscle performance, fatigue reduction, management of blood lactate production, analgesia and in the increase of VO2 maximal, favoring the increase of ATP production and thus the energy metabolism. The association of PBM applied before high-intensity treadmill training shows physiological improvements both in normoxic (Nor) and hypoxic (Hip) conditions. Anaerobic capacity (AC) is the maximum amount of ATP that can be resynthesized by anaerobic metabolism and is an important predictor of high-intensity exercise since an athlete's ability to perform efforts to increase maximal oxygen consumption (VO2max) depends on AL. In view of the above information the main objective of the present research project will be to investigate the effects of PBM on AC under normoxic and hypoxic conditions in amateur runners. To test the effects of exercise training on anaerobic capacity under normoxic and hypoxic conditions, 7 individuals will be randomly submitted to four maximal efforts to exhaustion with intensity corresponding to 110% of VO2max in Hip, Nor, Hip+Ebio and Nor+Ebio conditions. These efforts will be used to estimate the AC, that is, the maximum accumulated deficit of alternative oxygen (MAODRED), from the sum of the energy contribution of the anaerobic and lactic metabolisms.

Conditions

Interventions

TypeNameDescription
DEVICEPhotobiomodulation therapyA previous application of photobiomodulation therapy was offered or not, for possible performance enhancement.

Timeline

Start date
2021-08-31
Primary completion
2022-07-01
Completion
2022-12-31
First posted
2022-10-27
Last updated
2022-10-27

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT05595564. Inclusion in this directory is not an endorsement.